BALA CYNWYD, Pa., Sept. 6, 2012 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Deltek, Inc.
("Deltek" or the "Company") (Nasdaq: PROJ) relating to the proposed
acquisition by Thoma Bravo, LLC.
("Thoma Bravo").
Under the terms of the transaction, Deltek shareholders will
receive only $13.00 in cash for each
share of Deltek stock they own. The investigation concerns possible
breaches of fiduciary duty and other violations of state law by the
Board of Directors of Deltek for not acting in the Company's
shareholders' best interests in connection with the sale process to
Thoma Bravo. The transaction may
undervalue the Company as Deltek stock traded at $14.25 a share as recently as August 21, 2012. In addition, an analyst has set
a price target on Deltek stock at $16.00 per share.
If you own shares of Deltek stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L.
Brodsky, Esquire or Evan J. Smith,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by
e-mail at investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/472-proj-deltek-inc.html, or by calling
toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC